Tashatuvango /
18 October 2016Americas

Astellas sues Japanese rival over Myrbetriq generic

Japanese pharmaceutical company Astellas has filed a complaint against another Japanese company, Sawai Pharmaceutical, for allegedly infringing its patents centring on the drug Myrbetriq (mirabegron).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at